These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7857537)

  • 1. Spinal cord stimulation for the treatment of progressive systemic sclerosis and Raynaud's syndrome.
    Francaviglia N; Silvestro C; Maiello M; Bragazzi R; Bernucci C
    Br J Neurosurg; 1994; 8(5):567-71. PubMed ID: 7857537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis: successful treatment of ulcerations, pain, Raynaud's phenomenon, calcinosis, and dysphagia by transcutaneous nerve stimulation. A case report.
    Kaada B
    Acupunct Electrother Res; 1984; 9(1):31-44. PubMed ID: 6145309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord stimulation utilization to treat the microcirculatory vascular insufficiency and ulcers associated with scleroderma: a case report and review of the literature.
    Provenzano DA; Nicholson L; Jarzabek G; Lutton E; Catalane DB; Mackin E
    Pain Med; 2011 Sep; 12(9):1331-5. PubMed ID: 21914119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of esophageal dysmotility and Raynaud's phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration.
    Kaada B
    Scand J Gastroenterol; 1987 Nov; 22(9):1137-46. PubMed ID: 3501154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis].
    Cordioli E; Virgilio S; Ghirardi R; Martinelli M
    Minerva Med; 1992 Nov; 83(11):739-44. PubMed ID: 1281297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon.
    Neuhauser B; Perkmann R; Klingler PJ; Giacomuzzi S; Kofler A; Fraedrich G
    Am Surg; 2001 Nov; 67(11):1096-7. PubMed ID: 11730228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis.
    Goodfield MJ; Rowell NR
    Br J Dermatol; 1988 Nov; 119(5):643-6. PubMed ID: 3207617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord stimulation for the treatment of pain and toe ulceration associated with systemic sclerosis: a case report.
    Ito H; Tanei T; Sugawara K; Sando Y; Hori N
    Fukushima J Med Sci; 2022 Apr; 68(1):37-41. PubMed ID: 35228457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of somatosensory profiles by spinal cord stimulation in primary Raynaud's syndrome.
    Münster T; Tiebel N; Seyer H; Maihöfner C
    Pain Pract; 2012 Jul; 12(6):469-75. PubMed ID: 22304658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raising awareness of Raynaud's phenomenon and scleroderma.
    Mawdsley AH; Brown SJ
    Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Raynaud phenomenon and ischemic ulcers associated to systemic sclerosis with hyperbaric oxygen.
    Ahijón-Lana M; Baragaño-Ordóñez E; Veiga-Cabello R; de la Cruz-Tapidor C; Carreira PE
    Reumatol Clin (Engl Ed); 2022 Apr; 18(4):246-248. PubMed ID: 34953734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of spinal cord stimulation in the treatment of severe Raynaud's disease of the hands.
    Sibell DM; Colantonio AJ; Stacey BR
    Anesthesiology; 2005 Jan; 102(1):225-7. PubMed ID: 15618807
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25. Ischemic pain in the extremities and Raynaud's phenomenon.
    Devulder J; van Suijlekom H; van Dongen R; Diwan S; Mekhail N; van Kleef M; Huygen F
    Pain Pract; 2011; 11(5):483-91. PubMed ID: 21435165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic connective tissue diseases in India, VI. Raynaud's disease and pre-progressive systemic sclerosis (Pre-PSS).
    Malaviya AN; Narayanan K; Tiwari SC; Khan KM; Raina V; Pande JN
    J Assoc Physicians India; 1983 Oct; 31(10):625-8. PubMed ID: 6671930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.